RxDoctor Payments Data

John Gashkoff, MD

Interventional Pain Medicine · Naperville, ILNPI 1356309694

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,505 of the $11,848 with a category attached, or 80.2%. It is spread thinly across 30 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,611 and has fallen 57.9% since, to $1,522 in 2025.

$11,848in general payments, 2019–2025

Across 270 payments — averaging $43.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Nevro Corp.$2K
  • Boston Scientific$2K
  • Saluda Medical Americas, Inc.$945
  • Relievant Medsystems, Inc.$912
  • Medtronic$485
  • plus $3K from 24 others

What the payments were for

  • Travel & lodging$1,79015%
  • Food & beverage$9,50580%
  • Education$5535%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,848 in reported general payments places this provider in the 80th percentile of 93 interventional pain medicine providers in Illinois.

See all interventional pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$231,984
Medicare patients
449
Services billed
6,124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl18$8,346
Xtampza ErOxycodone Myristate12$4,274
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen84$4,047
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen210$3,564
Gabapentin114$1,857
Morphine Sulfate ErMorphine Sulfate51$1,787
Pregabalin58$1,742
Fentanyl12$1,237
Tramadol Hcl98$538
Baclofen22$238
Hydromorphone Hcl19$232
Acetaminophen-CodeineAcetaminophen With Codeine17$180
Duloxetine Hcl17$174
Methylprednisolone37$153
Cyclobenzaprine Hcl23$139

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Naperville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →